News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PDUFA V Sets New Course for Regulatory Science – Joint Biotechnology Industry Organization (BIO)/Pharmaceutical Research and Manufacturers of America (PhRMA) Statement


10/1/2012 10:09:59 AM

WASHINGTON--(BUSINESS WIRE)--Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani and Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood today released the following joint statement on the implementation of the Prescription Drug User Fee Act (PDUFA V):

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES